| identified miR-29a and miR-330-5p as two new tumor suppressive miRNAs that inhibit the expression of MUC1 oncogenic mucin in pancreatic cancer cells. | pancreatic, |
| MiR-330-3p acts as a tumor suppressor by regulating Bmi-1 expression in osteosarcoma. | osteosarcoma, |
| MiR-330-3p functions as a tumor suppressor that regulates glioma cell proliferation and migration by targeting CELF1 | glioma, |
| MicroRNA-330 is an oncogenic factor in glioblastoma cells by regulating SH3GL2 gene. | glioblastoma, |
| SH3GL2 gene was identified as the target of miR-330. miRNA-330 plays an oncogenic role in human glioblastoma by regulating SH3GL2 gene and might be a new therapeutic target of human glioblastoma. | glioblastoma, |
| MicroRNA-330-3p functions as an oncogene in human esophageal cancer by targeting programmed cell death 4. | esophageal, |
| Upregulation of miR-330 is associated with poor prognosis and contributes to more aggressive phenotypes of Hepatocellular Carcinoma . The oncogenic role of miR-330 in Hepatocellular Carcinoma is linked to downregulation of ING4. | liver, |
| miR-330 negatively regulated the expression of SH3GL2 in GSCs, which promoted the oncogenic progression of GSCs through activating ERK and PI3K/AKT signaling pathways. | None |